News from vermillion, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 19, 2015, 09:00 ET

Vermillion Announces Key Medical Policy Coverage for OVA1® Test

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced additional medical policy...

Aug 13, 2015, 09:00 ET

Vermillion Reports Second Quarter 2015 Financial Results and Business Update

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, reported financial results for the second...

Jul 30, 2015, 08:00 ET

Vermillion to Report Second Quarter 2015 Financial Results and Host Investor Conference Call on August 13

Vermillion, Inc. (VRML), a bio-analytical solutions company focused on gynecologic disease, announced today it will report its second quarter 2015...

Jul 17, 2015, 11:00 ET

Vermillion, Inc. Announces Closing of $18.8 Million Public Offering of Common Stock

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced the closing of an...

Jul 14, 2015, 09:00 ET

Vermillion, Inc. Prices $16.4 Million Public Offering of Common Stock

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced the pricing of an...

Jul 13, 2015, 16:01 ET

Vermillion, Inc. Announces Proposed Public Offering of Common Stock

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that it intends to offer...

Jul 13, 2015, 09:00 ET

ASPiRA Labs Receives New York State Permit

Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that its wholly owned...

May 21, 2015, 09:00 ET

Vermillion Approved for a $7.5 Million Grant by the Cancer Prevention and Research Institute of Texas

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that it has been approved...

May 14, 2015, 09:20 ET

Positive Top-Line Results Regarding OVA2 Development and Clinical Validation to be Presented at American Society for Clinical Oncology Conference

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced publication of two...

May 11, 2015, 16:01 ET

Vermillion Reports First Quarter 2015 Financial Results and Provides Business Update

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, reported financial results for the first...

Apr 27, 2015, 16:35 ET

Vermillion Announces Expanded Medical Policy Coverage for OVA1® Test

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced expanded medical policy...

Apr 27, 2015, 08:35 ET

Vermillion to Report First Quarter 2015 Financial Results and Host Investor Conference Call on May 11

Vermillion, Inc. (VRML), a bio-analytical solutions company focused on gynecologic disease, announced today it will report first quarter 2015...

Apr 14, 2015, 09:00 ET

Kaiser Permanente Southern California and Vermillion Collaborate to Improve Best-Practice Care for Women with Ovarian Cancer

Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced the initiation of a strategic...

Apr 02, 2015, 08:00 ET

Vermillion Names Fred Ferrara to Newly Created CIO Post

Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced it named Fred Ferrara to the...

Mar 27, 2015, 08:00 ET

Landmark OVA1 Cost-Effectiveness Analysis Compared to Current Standard of Care for Ovarian Cancer Presented at American College of Medical Quality Conference

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced initial results from a...

Mar 25, 2015, 08:00 ET

Vermillion Reports Fourth Quarter and Full Year 2014 Results

Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, reported on its results for the fourth quarter...

Mar 17, 2015, 16:35 ET

Vermillion and Quest Diagnostics Announce New Commercial Agreement

 Vermillion, Inc. (Nasdaq:  VRML), a bio-analytical solutions company focused on gynecologic disease, today announced a new...

Mar 05, 2015, 16:35 ET

Vermillion to Report Fourth Quarter and Year-End 2014 Financial Results and Host an Investor Conference Call on March 25

Vermillion, Inc. (Nasdaq: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today it will report fourth quarter...

Mar 03, 2015, 16:35 ET

Vermillion To Present at 27th Annual ROTH Conference on March 9

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced management will present at...

Feb 12, 2015, 16:22 ET

Vermillion Receives ISO 13485 Certification for Company's Quality Management System

Vermillion, Inc. (Nasdaq: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that the Company has been...